Actively Recruiting

Phase 3
Age: 18Years - 99Years
All Genders
NCT07298330

A Trial Evaluating Brelovitug vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta Infection (AZURE-4)

Led by Mirum Pharmaceuticals, Inc. · Updated on 2026-03-02

80

Participants Needed

27

Research Sites

154 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This is a Phase 3, global, randomized, open-label, multicenter trial designed to evaluate the safety and efficacy of chronic treatment with brelovitug (BJT-778) for chronic hepatitis delta virus (HDV) infection. The objective of this study is to test the safety and effectiveness of brelovitug compared to delayed treatment.

CONDITIONS

Official Title

A Trial Evaluating Brelovitug vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta Infection (AZURE-4)

Who Can Participate

Age: 18Years - 99Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Willing and able to provide written informed consent
  • Diagnosed with chronic hepatitis delta virus (HDV) infection
  • HDV RNA level greater than 500 IU/mL at screening
  • ALT level above the upper limit of normal at screening
  • Willing to take or already taking hepatitis B virus nucleos(t)ide therapy
Not Eligible

You will not qualify if you...

  • Pregnant or nursing females
  • Unwilling to comply with contraception requirements during the study
  • Difficulty with blood collection or poor venous access for phlebotomy
  • Clinical hepatic decompensation, such as ascites, encephalopathy, or variceal hemorrhage
  • History of solid organ or bone marrow transplantation
  • Presence of other liver diseases not related to HBV/HDV, such as metabolic dysfunction-associated steatohepatitis, alcohol-associated hepatitis, cholestatic liver disease, or hepatocellular carcinoma

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 27 locations

1

University of California, Davis

Davis, California, United States, 95616

Actively Recruiting

2

Kaiser Permanente Medical Center

Sacramento, California, United States, 95661

Actively Recruiting

3

Quest Clinical Research

San Francisco, California, United States, 94115

Actively Recruiting

4

Denver Health Medical Center

Denver, Colorado, United States, 80204

Actively Recruiting

5

Alliance Clinical, Las Vegas

Las Vegas, Nevada, United States, 89019

Actively Recruiting

6

Cleveland Clinic

Cleveland, Ohio, United States, 44195

Actively Recruiting

7

Prime Clinical Research Inc

Mansfield, Texas, United States, 76063

Actively Recruiting

8

University of Utah

Salt Lake City, Utah, United States, 84132

Actively Recruiting

9

Erasme Hospital

Brussels, Belgium

Actively Recruiting

10

University Hospital Antwerp (UZA)

Edegem, Belgium

Actively Recruiting

11

University Hospital Center Sart-Tilman

Liège, Belgium

Actively Recruiting

12

Acibadem City Clinic University Multiprofile Hospital for Active Treatment Tokuda

Sofia, Bulgaria, 1407

Actively Recruiting

13

Hospital Service LTD

Kutaisi, Georgia, 4608

Actively Recruiting

14

Diakori LLC

Tbilisi, Georgia, 0159

Actively Recruiting

15

JSC T. Tsertsvadze Infectious Diseases, AIDS and Clinical Immunology Research Center

Tbilisi, Georgia, 0159

Actively Recruiting

16

LTD Academician Vakhtang Bochorishvili Clinic

Tbilisi, Georgia, 0160

Actively Recruiting

17

Central Hospital of Southern Pest National Institute of Hematology and Infectious Diseases

Budapest, Hungary, H-1097

Actively Recruiting

18

Fejer County St. Gyorgy University Teaching Hospital

Székesfehérvár, Hungary, H-8000

Actively Recruiting

19

Soroka University Medical Center

Beersheba, Israel, 8410101

Actively Recruiting

20

HaEmek Medical Center

Haifa, Israel, 3296043

Actively Recruiting

21

Aga Khan University & Hospital

Karachi, Karachi, Pakistan, 74800

Actively Recruiting

22

Kaohsiung Medical University Chung-Ho Memorial Hospital

Kaohsiung City, Taiwan, 807377

Actively Recruiting

23

E-Da Hospital

Kaohsiung City, Taiwan, 82445

Actively Recruiting

24

National Taiwan University Hospital

Taipei, Taiwan, 100225

Actively Recruiting

25

Limited Liability Company "Medical Center Health and Rehabilitation "100 Percent Life"

Poltava, Ukraine, 36000

Actively Recruiting

26

Public Non-Profit Enterprise "Central City Hospital" of Rivne City Council

Rivne, Ukraine, 33018

Actively Recruiting

27

Research Institute of Virology of the Republic of Uzbekistan

Tashkent, Uzbekistan, 100194

Actively Recruiting

Loading map...

Research Team

C

Clinical Trials Mirum

CONTACT

M

Mirum Pharmaceuticals, Inc., Clinical Trials

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

A Trial Evaluating Brelovitug vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta Infection (AZURE-4) | DecenTrialz